Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties
A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Gower, Brad L Herman, Clifford J Lai, Tsz Chung Park, Jae Han Feng, Kai |
description | A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition extended release of the API and has abuse deterrent features. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2017216904BB2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2017216904BB2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2017216904BB23</originalsourceid><addsrcrecordid>eNqNjTsOwjAQBdNQIOAOW9AiJQGBKAnicwCo0WI_EkvO2rI3guOTggNQvZFmpDct2osfTOhZhIVMEGUnTlqKHaeeDQZ1hv1o-hiyUxck09tpR_goxMJSggdnEIslfg4jWShSgijFFCKSOuR5MXmxz1j8dlYsz6fb8bpCDA_kOF4J9HG412W1q6vtvtw0Tb3-M_sCDKJCug</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties</title><source>esp@cenet</source><creator>Gower, Brad L ; Herman, Clifford J ; Lai, Tsz Chung ; Park, Jae Han ; Feng, Kai</creator><creatorcontrib>Gower, Brad L ; Herman, Clifford J ; Lai, Tsz Chung ; Park, Jae Han ; Feng, Kai</creatorcontrib><description>A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition extended release of the API and has abuse deterrent features.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211118&DB=EPODOC&CC=AU&NR=2017216904B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20211118&DB=EPODOC&CC=AU&NR=2017216904B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Gower, Brad L</creatorcontrib><creatorcontrib>Herman, Clifford J</creatorcontrib><creatorcontrib>Lai, Tsz Chung</creatorcontrib><creatorcontrib>Park, Jae Han</creatorcontrib><creatorcontrib>Feng, Kai</creatorcontrib><title>Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties</title><description>A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition extended release of the API and has abuse deterrent features.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjTsOwjAQBdNQIOAOW9AiJQGBKAnicwCo0WI_EkvO2rI3guOTggNQvZFmpDct2osfTOhZhIVMEGUnTlqKHaeeDQZ1hv1o-hiyUxck09tpR_goxMJSggdnEIslfg4jWShSgijFFCKSOuR5MXmxz1j8dlYsz6fb8bpCDA_kOF4J9HG412W1q6vtvtw0Tb3-M_sCDKJCug</recordid><startdate>20211118</startdate><enddate>20211118</enddate><creator>Gower, Brad L</creator><creator>Herman, Clifford J</creator><creator>Lai, Tsz Chung</creator><creator>Park, Jae Han</creator><creator>Feng, Kai</creator><scope>EVB</scope></search><sort><creationdate>20211118</creationdate><title>Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties</title><author>Gower, Brad L ; Herman, Clifford J ; Lai, Tsz Chung ; Park, Jae Han ; Feng, Kai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2017216904BB23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Gower, Brad L</creatorcontrib><creatorcontrib>Herman, Clifford J</creatorcontrib><creatorcontrib>Lai, Tsz Chung</creatorcontrib><creatorcontrib>Park, Jae Han</creatorcontrib><creatorcontrib>Feng, Kai</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Gower, Brad L</au><au>Herman, Clifford J</au><au>Lai, Tsz Chung</au><au>Park, Jae Han</au><au>Feng, Kai</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties</title><date>2021-11-18</date><risdate>2021</risdate><abstract>A pharmaceutical composition comprising at least one active pharmaceutical ingredient (API) or a pharmaceutically acceptable salt thereof, a glucomannan, a first polyalkylene oxide having an average molecular weight of no more than 300,000, and a second polyalkylene oxide having an average molecular weight of at least 1,000,000 and methods of making. The pharmaceutical composition extended release of the API and has abuse deterrent features.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_AU2017216904BB2 |
source | esp@cenet |
subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
title | Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T08%3A03%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Gower,%20Brad%20L&rft.date=2021-11-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2017216904BB2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |